Pay in 4 interest-free payments of $27.50 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A
Mollenhauer HH
Clomethiazole (30 μM) at low concentration also potentiates the action of GABA in both cell types
the tumor sizes are also markedly decreased by (+)-Apogossypol treatment (P<0
and exhibits antiadrenergic effects by noncompetitive binding to β-adrenergic receptors
Anlotinib HCl Catalog No.:M33595-10 MMAF sodium (Monomethylauristatin F sodium)Anlotinib, also known as AL3818 and Catequentinib, is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti angiogenic activities. Upon administration, anlotininib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth. Product information CAS Number: 1360460 82 7 Molecular Weight: 480. 36 Formula:
US$ 197.42
US$ 188.89
US$ 188.88
US$ 117.30
US$ 188.89
US$ 163.90
US$ 270.99
US$ 117.44
US$ 294.00
US$ 129.00
US$ 141.26
US$ 173.25
US$ 294.00
US$ 75.00
US$ 75.00
US$ 112.23
US$ 975.94
US$ 138.60